NCT03888690 (ReVaDo) is a NA clinical trial of Virtual Reality Headset in Procedural Pain, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT03888690?

NCT03888690 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT03888690?

Interventions in NCT03888690: Virtual Reality Headset.

What condition does NCT03888690 study?

NCT03888690 studies Procedural Pain, Procedural Anxiety, Virtual Reality.

Is NCT03888690 still recruiting?

NCT03888690 is currently status unknown. Last updated 25 March 2019.

Last reviewed 2019-03-25 · How we verify

NCT03888690: ReVaDo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Virtual Reality Distraction on Procedural Pain for Children and Adolescents in Onco-Hematology Unit.

Status unknown NA Last updated 25 March 2019

What this trial tests

NA trial testing Virtual Reality Headset in Procedural Pain in 96 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
31 March 2020

30 June 2020

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	supportive care
Enrollment	96
Start date	1 April 2019
Primary completion	31 March 2020
Estimated completion	30 June 2020
Sites	1 location across France

Drugs / interventions tested

Virtual Reality Headset

Conditions studied

Procedural Pain — all drugs for Procedural Pain →
Procedural Anxiety — all drugs for Procedural Anxiety →
Virtual Reality — all drugs for Virtual Reality →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 8 to 17, any sex, with Procedural Pain or Procedural Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Demonstrate the effectiveness of the Virtual Reality (VR) distraction on pain reduction in children and adolescents in onco-hematology unit compared to standard practice. * Evaluate the impact of VR on the level of anxiety induced by invasive procedures * Report traceability of assessment of pain and anxiety scores, and reproducibility of procedural analgesia techniques. * Evaluate the impact of VR on the short-term consequences of procedural pain, especially in terms of phobia of care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Virtual reality distraction for acute pain in children.
Lambert V, Boylan P, Boran L, Hicks P, et al · · 2020 · cited 50× · PMID 33089901 · DOI 10.1002/14651858.cd010686.pub2
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review.
Comparcini D, Simonetti V, Galli F, Saltarella I, et al · · 2023 · cited 19× · PMID 36765945 · DOI 10.3390/cancers15030985

Verify or expand the search:

Other trials of Virtual Reality Headset

Trials testing the same drug.

NCT06917456 — Novel VR Intervention for Use in Psychiatric Inpatient Wards · completed
NCT07325695 — Effect of Virtual Reality Glasses on Pain and Anxiety During Intrauterine Device Insertion in Women · NA · completed
NCT07039812 — The Effect of Virtual Reality and Eye Mask During Dressing After CABG Surgery · NA · recruiting
NCT06589739 — Chest Drain Insertion Assisted by Virtual Reality · NA · not yet recruiting
NCT06296147 — Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy · NA · recruiting

Other recruiting trials for Procedural Pain

Currently open trials in the same condition.

NCT07512791 — Effect of Bagua Auriculotherapy on Pain in Patients Undergoing Hysteroscopy · NA · active not recruiting
NCT07094451 — Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures · NA · recruiting
NCT06913270 — Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care · NA · recruiting
NCT07440342 — TEAS for Sedation During ERCP: A Multicenter Trial · NA · recruiting
NCT06346171 — VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain · NA · active not recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03888690 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 25 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03888690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing